The University of California San Diego has launched a master’s program for healthcare professionals looking to specialize in the development and delivery of precision oncology medicine.
The Master of Advanced Studies in Precision Medicine Therapeutics in Oncology program aims to address the imbalance between the growing number of precision oncology therapies available and the few cancer patients who actually receive these treatments, according to a May 12 news release from the university.
Applications for the inaugural class are expected to open in September, with the program slated to begin in fall 2026 at the UC San Diego campus.
The program can be completed in nine to 18 months and is “ideal for health care professionals looking to specialize in precision oncology, researchers interested in the application of AI in oncology, genomics, diagnostics and therapeutic applications, and industry professionals working in drug development, clinical trials and health care policy,” the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.